In addition to being described as a tumour suppressor gene in numerous solid tumours and haematological malignancies, Klotho represents a possible therapeutic target for patients with these diseases, the majority of whom have limited treatment options [7,27,43] (Table 1). The gene discussed is KL; the disease is neoplasm.